Disc Medicine, Inc.

NasdaqGM IRON

Disc Medicine, Inc. Market Capitalization on January 14, 2025: USD 1.72 B

Disc Medicine, Inc. Market Capitalization is USD 1.72 B on January 14, 2025, a 11.70% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Disc Medicine, Inc. 52-week high Market Capitalization is USD 2.01 B on December 10, 2024, which is 16.67% above the current Market Capitalization.
Disc Medicine, Inc. 52-week low Market Capitalization is USD 654.05 M on April 25, 2024, which is -61.99% below the current Market Capitalization.
Disc Medicine, Inc. average Market Capitalization for the last 52 weeks is USD 1.32 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGM: IRON

Disc Medicine, Inc.

CEO	Dr. John D. Quisel Esq., J.D., Ph.D.
IPO Date	Aug. 12, 2020
Location	United States
Headquarters	321 Arsenal Street
Employees	82
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Key trends

Past 5 years